Transform our go-to-market model

We are partnering with others to address the patient affordability challenge by exploring new, flexible payment approaches, including value-based agreements, and being bold in how we expand access to our medicines.
It’s easy to say that everything we do is driven by our purpose, but our 2019 milestones – everything from regulatory approvals of breakthrough therapies to announcements surrounding our current R&D programs – show the multitude of ways we are helping patients. While we continue to navigate the issues that dominate the environment today, we’ll do so with a singular goal to help patients.

Joan Campion

Vice President, Chief Communications Officer
Transform our go-to-market model
Unleash the power of our people
Deliver first-in-class science
Transform our go-to-market model
Win the digital race in pharma
Lead the conversation